On June 24, Medpace Holdings rose 7.2% in regular trading, trading at $507.6 USD/share, with Turnover of $90.19 million.
Within the Life Sciences Tools & Services sector where Medpace Holdings belongs, the overall sector showed broad strength. Among individual stocks, Icon PLC up 12.34%, Illumina up 6.33%, Danaher up 4.9%, Mettler-Toledo up 4.38%, Thermo Fisher Scientific up 3.98%.
Medpace Holdings is a global leading clinical contract research organization (CRO), specializing in science-driven outsourced clinical development services for the biotechnology, pharmaceutical, and medical device industries, covering Phase I through Phase IV clinical development with particular strength in oncology, metabolic diseases, and cardiology.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments